High-risk human papillomavirus testing as a primary screening for cervical cancer: position statement by the Korean Society of Obstetrics and Gynecology and the Korean Society of Gynecologic Oncology

Mostrar otras versiones (1)

Based on emerging data and current knowledge regarding high-risk human papillomavirus (hrHPV) testing as a primary screening for cervical cancer, the Korean Society of Obstetrics and Gynecology and the Korean Society of Gynecologic Oncology support the following scientific facts: • Compared to cytol...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Tae-Wook, Kim, Miseon, Kim, Young-Han, Kim, Yong Beom, Kim, Jayeon, Kim, Jae-Weon, Park, Mi Hye, Park, Joo Hyun, Rhee, Jeong Ho, Lim, Myong Cheol, Hong, Joon-Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Obstetrics and Gynecology; Korean Society of Contraception and Reproductive Health; Korean Society of Gynecologic Endocrinology; Korean Society of Gynecologic Endoscopy and Minimal Invasive Surgery; Korean Society of Maternal Fetal Medicine; Korean Society of Ultrasound in Obstetrics and Gynecology; Korean Urogynecologic Society 2020
Materias:
Position Statement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073357/
https://www.ncbi.nlm.nih.gov/pubmed/32206648
http://dx.doi.org/10.5468/ogs.2020.63.2.107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073357/
https://www.ncbi.nlm.nih.gov/pubmed/32206648
http://dx.doi.org/10.5468/ogs.2020.63.2.107

Ejemplares similares